NEW YORK (GenomeWeb) – Agilent Technologies this week announced that its board has approved a quarterly dividend of $.13 per share of common stock, payable on Oct. 25 to all shareholders of record as of the close of business on Oct. 3.


Edico Genome announced this week that its DRAGEN Bio-IT Platform is now available on Illumina's BaseSpace Sequence Hub. Users can now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.